Computational Biology Lab at the University of Mississippi

Dr. Pavel’s Lab is primarily focused on developing multi-omics approaches for biomarker and drug discovery in immunological diseases and cancer. Dr. Pavel has broad experience in evaluating various immunomodulators in clinical trials and assessing their effect on key inflammatory pathways. She is currently applying machine learning and computational approaches to evaluate the wiring of immune axes and define an immune modulation spectrum across multiple immunological diseases to facilitate drug discovery and repurposing. Her work has direct implications on the current research on SARS-CoV-2 by screening underlying molecular mechanisms associated with high-risk populations.